StockData
CTT Pharmaceutical Holdings, Inc. logo

CTT Pharmaceutical Holdings, Inc. (CTTH) stock

CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)

Close on Oct 16, 2026Market cap $1.26MP/E –Yield –

CTT Pharmaceutical pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

CTT Pharmaceutical's pe ratio was 44.0× on Apr 30, 2012.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2012Apr 30, 201244.0×−240.4
2011Dec 30, 2011284.4×–

More CTT Pharmaceutical figures

See a number that looks wrong?